APA način citiranja

Strand, V., Mysler, E., Moots, R. J., Wallenstein, G. V., DeMasi, R., Gruben, D., . . . Fleischmann, R. (2019). Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: A phase IIIB/IV trial. RMD Open.

Čikaški stil citiranja

Strand, Vibeke, et al. "Patient-reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial." RMD Open 2019.

MLA način citiranja

Strand, Vibeke, et al. "Patient-reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial." RMD Open 2019.